VASH2 is reportedly expressed in many common tumors, like hepatocellular carcinoma, serous ovarian adenocarcinoma and gastric cancer, and participates in the program of tumor metabolism, such as angiogenesis [8], [10], [44]. Here, VASH2 is linked to hepatocellular carcinoma.